Biomedical non-woven textiles Market Size, Production, Sales, Average Product Price, Market Share, Import vs Export 

Biomedical Non-Woven Textiles Market: Evolving Trends and Drivers of Growth 

Biomedical non-woven textiles market size is estimated to be $11650 Million in 2025. The market was $11148 Million in 2024 and will reach $15854 Million by 2032.
The Biomedical Non-Woven Textiles Market has witnessed a significant surge in demand over the last decade. This growth trajectory is propelled by advances in healthcare, an increasing focus on infection control, and rising demand for disposable medical products. The non-woven textiles, which are a fabric-like material made from fibers bonded together mechanically, thermally, or chemically, offer unmatched benefits in medical applications such as wound care, surgical gowns, masks, and hygiene products. The market’s expansion is a direct result of the rising healthcare needs across the globe, especially in light of the ongoing health crises. This article explores the key trends driving the Biomedical Non-Woven Textiles Market and its projected growth. 

Rising Demand for Disposable Medical Products 

The demand for disposable medical products has been a key driver of the Biomedical Non-Woven Textiles Market. Non-woven fabrics have become an essential material in the healthcare industry due to their ability to meet hygiene standards while being cost-effective and easy to manufacture. Disposable products such as surgical drapes, face masks, gowns, and wound dressings are increasingly being preferred for their effectiveness in reducing the risk of contamination. 

As of recent projections, the global healthcare industry is expanding at an unprecedented rate. The disposable medical products segment is projected to grow at a compound annual growth rate (CAGR) of over 6% between 2023 and 2030, making it a dominant player in the Biomedical Non-Woven Textiles Market. This growth is primarily driven by rising awareness of infection control and a preference for hygiene-maintaining solutions, particularly in hospitals, clinics, and care facilities. 

Technological Innovations and Advancements 

The Biomedical Non-Woven Textiles Market is also seeing substantial growth due to ongoing technological advancements in textile manufacturing. Innovations such as spunbond, meltblown, and carded non-woven technologies have enhanced the performance of biomedical textiles, making them more suitable for high-performance applications in medical care. 

For example, meltblown technology, which involves the extrusion of polymer fibers into a fine mesh, is frequently used to create highly effective face masks and protective gowns. These innovations ensure that the Biomedical Non-Woven Textiles Market remains at the forefront of medical material solutions. The ongoing development of nanotechnology, aimed at improving the filtration and antibacterial properties of non-woven textiles, will further fuel the demand in healthcare applications. 

The technological capabilities of non-woven textiles also play a vital role in their application for advanced medical treatments. Medical-grade non-woven fabrics are being used in wound care, offering properties such as moisture control and anti-bacterial resistance, which ensure faster healing and reduced infection risks. These improvements are resulting in a steady increase in the demand for biomedical textiles in clinical settings. 

Surge in Surgical and Healthcare Procedures 

The rise in the number of surgeries, particularly elective procedures, is contributing significantly to the Biomedical Non-Woven Textiles Market growth. As surgical practices become more advanced and accessible, the demand for sterile and single-use non-woven textiles, including gowns, drapes, and surgical masks, is increasing. 

For instance, the global number of surgical procedures has increased dramatically in recent years. In 2022 alone, it was estimated that over 300 million surgeries were performed worldwide, and this number is expected to continue to rise. The continuous increase in surgeries will necessitate an increased supply of non-woven textiles to maintain hygiene standards, making them indispensable in the medical industry. 

Growing Awareness of Infection Control 

As healthcare standards evolve, infection control measures have become a critical aspect of medical practice. The COVID-19 pandemic brought heightened attention to the need for protective medical gear, such as face masks, isolation gowns, and surgical drapes. As a result, the demand for biomedical non-woven textiles surged dramatically during the pandemic. 

The growing awareness of the importance of infection control in healthcare settings, including hospitals, clinics, and even home care environments, is expected to continue driving the Biomedical Non-Woven Textiles Market. Products such as wound dressings, which help prevent bacterial growth, and sterilized surgical drapes, which prevent contamination during procedures, are now seen as essential to healthcare infrastructure. 

Additionally, the rise of antimicrobial treatments for non-woven textiles has contributed significantly to the ongoing demand. Non-woven textiles are increasingly being treated with antimicrobial agents to enhance their infection-resistant properties, thus expanding their use in sensitive medical environments. 

Increasing Geriatric Population and Chronic Illnesses 

The growing geriatric population worldwide is another significant factor driving the demand for biomedical non-woven textiles. As the elderly population expands, the prevalence of chronic diseases such as diabetes, cardiovascular conditions, and joint disorders increases. These conditions often require long-term care, including wound management and hygiene products, where non-woven textiles play an important role. 

With an estimated 1.4 billion people expected to be over 60 years old by 2030, the need for specialized care, especially wound care products, is poised to increase significantly. Non-woven textiles used in wound dressings, bandages, and other medical care products are essential in providing comfort, preventing infection, and ensuring proper healing in elderly patients. This trend is expected to fuel the Biomedical Non-Woven Textiles Market further. 

Expansion of Home Healthcare Market 

The shift towards home-based healthcare services is another emerging trend that is driving growth in the Biomedical Non-Woven Textiles Market. Non-woven textiles are increasingly used in home care settings for the management of wounds, surgical recovery, and hygiene products. With more patients opting for home healthcare, driven by factors such as cost-effectiveness and convenience, the demand for high-quality biomedical non-woven textiles is on the rise. 

This shift is particularly relevant in countries with an aging population, such as Japan, the United States, and many European nations, where healthcare services are being decentralized to reduce the pressure on hospitals. As home healthcare becomes more prevalent, the biomedical non-woven textiles used in this segment are expected to see continued growth. 

Emerging Markets and Regional Expansion 

The Biomedical Non-Woven Textiles Market is also seeing rapid expansion in emerging markets, particularly in Asia-Pacific, Latin America, and Africa. Increased healthcare spending in these regions, combined with rising awareness of healthcare hygiene, is driving the demand for biomedical textiles. For instance, the Asia-Pacific region alone is expected to account for more than 40% of the global market share by 2030, primarily driven by the growing healthcare infrastructure in countries like India and China. 

This regional expansion is also influenced by the rising middle-class population in developing countries, who are increasingly seeking quality healthcare products. Non-woven textiles, with their versatility and cost-effectiveness, are expected to dominate in these regions, especially in hospital and clinical settings. 

Biomedical Non-Woven Textiles Market Size and Projections 

The Biomedical Non-Woven Textiles Market is anticipated to experience robust growth over the next decade. Driven by continuous technological innovations, a rising awareness of infection control, and the increasing demand for disposable medical products, the market size is projected to expand at a CAGR of 7.5% between 2023 and 2030. 

The market’s size is expected to surpass USD 12 billion by 2030, driven by the aforementioned trends. With healthcare expenditure globally increasing, the demand for biomedical non-woven textiles is poised to play a crucial role in maintaining medical hygiene and quality. This rapid growth presents both opportunities and challenges for manufacturers and healthcare providers to innovate and meet evolving market demands. 

“Track Country-wise Biomedical non-woven textiles Production and Demand through our Database”

• • • Biomedical non-woven textiles sales volume database for 29+ countries worldwide

Geographical Demand in the Biomedical Non-Woven Textiles Market 

The demand for biomedical non-woven textiles is not uniform across regions. There is a significant variation in demand due to factors such as healthcare infrastructure, economic development, and healthcare spending. The geographical distribution of the Biomedical Non-Woven Textiles Market is shaped by these elements, influencing both the scale and growth rate of the market in different regions. 

North America holds a substantial share of the global market, driven primarily by the advanced healthcare system in the United States and Canada. The rising prevalence of chronic diseases, an aging population, and the increasing need for disposable medical products contribute significantly to the demand for biomedical non-woven textiles in this region. Non-woven textiles are used extensively for wound care, surgical gowns, face masks, and hygiene products in healthcare facilities across the region. Furthermore, the ongoing push for infection control and hygiene practices, accelerated by the COVID-19 pandemic, has fortified the demand for these products. In fact, the North American Biomedical Non-Woven Textiles Market is projected to grow at a steady CAGR of 6.3% over the next five years. 

In Europe, the market is witnessing a similar growth trajectory, with an increased emphasis on healthcare and hygiene. Germany, France, and the UK are key players in this region, where the demand for high-quality medical products is on the rise. The European market is witnessing growth in the adoption of advanced non-woven textiles in various applications, such as wound care, infection prevention, and surgical drapes. Moreover, government spending on healthcare and infection control policies are expected to sustain this demand. The European Biomedical Non-Woven Textiles Market is expected to grow at a CAGR of 5.8%, with a focus on eco-friendly and sustainable medical textiles becoming a notable trend. 

The Asia-Pacific region, on the other hand, is showing the most dynamic growth. Countries like China, India, and Japan are rapidly advancing in terms of healthcare infrastructure and are investing significantly in medical technology and hygiene solutions. The growing middle class, along with the rise in healthcare expenditures, is accelerating demand for biomedical non-woven textiles. Asia-Pacific’s market share is projected to surpass 40% by 2030, with a CAGR of approximately 8%. The increased adoption of non-woven textiles in hospitals, clinics, and home care settings, especially in the treatment of chronic diseases and wound care, is expected to further boost this growth. 

Manufacturing Trends in the Biomedical Non-Woven Textiles Market 

Manufacturing plays a pivotal role in the growth of the Biomedical Non-Woven Textiles Market. As demand for non-woven textiles increases across the healthcare sector, manufacturers are adapting their processes to meet the evolving needs of medical applications. The development of high-performance non-woven fabrics with specialized features, such as antimicrobial properties, enhanced filtration, and breathability, is one of the key trends in manufacturing. 

The use of advanced technologies such as spunbond, meltblown, and carded technologies has been instrumental in producing biomedical non-woven textiles that meet stringent medical requirements. These manufacturing processes allow for the production of fabrics that are lightweight, cost-effective, and provide superior functionality. For example, meltblown technology, known for its ability to produce fine, highly effective fibers, is widely used in the production of surgical masks and face shields, making it an integral part of the biomedical non-woven textiles manufacturing process. 

A growing trend in manufacturing is the focus on sustainability. Non-woven textiles are traditionally made from polypropylene, but with increasing environmental awareness, manufacturers are exploring alternative raw materials such as biodegradable polymers. This shift is expected to reduce the environmental footprint of biomedical non-woven textiles, which is increasingly becoming a selling point in healthcare procurement. For example, the introduction of plant-based and recyclable non-woven fabrics is gaining traction in both medical and general textile markets. 

Additionally, innovations in the biomedical non-woven textiles manufacturing process are making products more cost-effective. With the increasing demand for non-woven textiles in emerging markets, especially in Asia-Pacific, manufacturing costs are becoming a key consideration. Manufacturers are looking to streamline production processes to reduce the cost of materials and labor, without compromising on the quality of the end product. 

Market Segmentation of the Biomedical Non-Woven Textiles Market 

The Biomedical Non-Woven Textiles Market can be segmented based on product type, application, and end-use. Each segment is witnessing growth driven by specific market demands and trends. 

In terms of product type, the market can be divided into spunbond, meltblown, airlaid, and others. Spunbond and meltblown non-woven textiles are the leading segments, owing to their high-performance properties. Meltblown non-woven textiles, in particular, are highly valued for their filtration efficiency and are predominantly used in the manufacturing of surgical masks and other protective wear. The spunbond non-woven textiles, with their durability and versatility, are used in wound care products, surgical gowns, and drapes. The combined share of these two categories accounts for over 65% of the total market demand. 

On the basis of application, the Biomedical Non-Woven Textiles Market is segmented into wound care, hygiene products, surgical gowns, masks, and others. Wound care is a rapidly growing segment, fueled by the increasing prevalence of chronic diseases and the aging population. In fact, wound care products such as dressings, bandages, and pads are expected to maintain steady demand, growing at a CAGR of 7.2% over the next five years. Similarly, hygiene products, including adult incontinence pads, diapers, and feminine hygiene products, are seeing a rise in demand, particularly in emerging economies where healthcare infrastructure is expanding. 

Surgical gowns and masks are another key application area, particularly in light of global health crises like the COVID-19 pandemic. The global demand for masks and gowns surged dramatically in 2020 and is expected to remain strong, as healthcare facilities continue to prioritize infection control and personal protection. This segment is anticipated to grow at a CAGR of 6.8%, driven by the ongoing necessity for personal protective equipment in healthcare settings. 

Price Trends in the Biomedical Non-Woven Textiles Market 

Price trends in the Biomedical Non-Woven Textiles Market are influenced by a variety of factors, including raw material costs, technological innovations in manufacturing, and regional supply-demand dynamics. The price of non-woven textiles has been rising steadily due to increased raw material costs, primarily driven by fluctuations in the price of polypropylene. The demand for more specialized materials, such as biodegradable or antimicrobial textiles, also contributes to the rising costs. 

Despite these challenges, the increasing scale of production and manufacturing efficiency has allowed for some price stabilization in the market. Bulk production, particularly in Asia-Pacific, has led to reduced costs for manufacturers, enabling them to offer non-woven textiles at more competitive prices. Additionally, as sustainability becomes a critical consideration, there is growing interest in recycled and eco-friendly alternatives, which are priced slightly higher due to the costs associated with processing and raw materials. 

In the global market, prices are also influenced by regional supply chain dynamics. For example, in North America and Europe, labor and production costs are higher, which can lead to premium pricing for biomedical non-woven textiles. In contrast, Asia-Pacific manufacturers benefit from lower production costs, which allows them to offer non-woven textiles at more affordable rates, driving demand in price-sensitive markets. 

The price trend for biomedical non-woven textiles will continue to be impacted by these factors, but with technological advancements in materials and manufacturing, price fluctuations are expected to become less volatile. Manufacturers are likely to focus on offering products with a balance of cost-effectiveness, quality, and sustainability, catering to the diverse needs of healthcare providers worldwide. 

“Biomedical non-woven textiles Manufacturing Database”

• • • Biomedical non-woven textiles top manufacturers market share for 29+ manufacturers
    • Top 9 manufacturers and top 19 manufacturers of Biomedical non-woven textiles in North America, Europe, Asia Pacific
    • Biomedical non-woven textiles sales dashboard, Biomedical non-woven textiles sales data in excel format

 

Top Manufacturers in the Biomedical Non-Woven Textiles Market 

The Biomedical Non-Woven Textiles Market is home to several dominant manufacturers that have established themselves as leaders by offering advanced, high-quality products. These manufacturers have earned their position through innovation, extensive product portfolios, and a focus on meeting the increasing demand for medical textiles. Below are some of the key players in the market, their product lines, and their impact on the sector. 

• Johnson & Johnson Services, Inc.

Johnson & Johnson is one of the most recognized names in the healthcare sector, with a substantial presence in the biomedical non-woven textiles market. The company’s offerings in the non-woven space include advanced wound care products, surgical drapes, gowns, and infection control solutions. Their popular product lines include the “Johnson & Johnson Wound Care” series, which utilizes non-woven materials for superior comfort, moisture management, and infection prevention. The company’s commitment to research and development in medical textiles ensures their continued leadership in the field. 

• Integra LifeSciences Corporation

Integra LifeSciences specializes in regenerative medical devices, and they have established a strong foothold in the biomedical non-woven textiles market with products designed for wound care, surgical drapes, and hemostasis. Their product range includes Integra® Biolayer, a non-woven textile used in surgical and wound care applications. This product line promotes faster wound healing by creating an optimal environment for tissue regeneration. Integra’s non-woven materials are also widely used for tissue engineering applications and other medical devices, reflecting the company’s commitment to advancing healthcare through innovation. 

• B. Braun Melsungen AG
  Braun Melsungen AG is another prominent player in the biomedical non-woven textiles market. The company offers a broad range of non-woven products designed for surgical and wound care applications. Their product lines, such as the B. Braun Wound Care and Sterile Drapes, are known for their high-performance standards. B. Braun’s non-woven materials are specifically engineered for high-quality infection control, offering effective barrier properties and comfort for patients during surgeries and treatments. Their strong reputation for quality and reliability makes them a top choice for healthcare providers worldwide.
• Medline Industries, Inc.

Medline Industries has a robust presence in the biomedical non-woven textiles market, particularly in the production and distribution of disposable medical products. They manufacture a wide variety of non-woven textiles for hospitals and healthcare facilities, including surgical gowns, drapes, and wound care products. Medline’s non-woven textiles are designed with a focus on patient safety and comfort. Their product offerings cater to both standard and high-performance medical requirements, and they are widely recognized for providing affordable, effective solutions in the healthcare industry. 

• Cardinal Health

Cardinal Health is a global healthcare services and products company, which has established itself as a leader in the biomedical non-woven textiles market. Cardinal Health manufactures non-woven textiles used in a variety of medical applications, including surgical drapes, gowns, and wound care products. Their surgical drapes and gowns are designed with optimal barrier protection to reduce the risk of contamination during surgeries. Cardinal Health’s biomedical non-woven textiles are known for their high-quality materials and effective infection control, making them a preferred choice among healthcare providers. 

• Freudenberg Group

Freudenberg Group is a leading manufacturer of non-woven fabrics, offering products used in a wide range of healthcare applications. Their medical non-woven materials are particularly prominent in surgical drapes, gowns, and hygiene products. Freudenberg’s innovative non-woven fabrics, such as their innovative air-laid and meltblown technologies, provide superior protection against contaminants. Their commitment to high-performance textiles has helped them establish a strong position in the biomedical non-woven textiles market. 

• DuPont

DuPont is a key player in the non-woven textiles market, offering a range of advanced materials for medical applications. Under its Tyvek® and Tychem® brands, DuPont produces high-performance non-woven fabrics used in protective apparel, including gowns, surgical drapes, and masks. These products are known for their durability, breathability, and protective qualities, making them essential in high-risk healthcare environments. DuPont’s non-woven textiles are also recognized for their ability to provide both physical and microbial protection. 

• Kimberly-Clark Professional

Kimberly-Clark Professional is a major manufacturer in the biomedical non-woven textiles market, focusing on hygiene and infection control products. They are particularly well-known for their range of non-woven surgical drapes, gowns, and face masks. Their products are engineered to provide maximum comfort while maintaining excellent protection and barrier performance. Kimberly-Clark Professional has a strong reputation in the healthcare sector for providing reliable, high-quality non-woven textiles for medical use. 

• Ahlstrom-Munksjö

Ahlstrom-Munksjö is a key player in the development of fiber-based materials, including non-woven textiles used in medical applications. Their non-woven materials are widely used in surgical drapes, gowns, and wound care products. The company’s focus on sustainability and innovation has led to the development of non-woven textiles that meet the growing demand for eco-friendly medical products. Ahlstrom-Munksjö’s high-performance non-woven textiles offer excellent barrier properties while ensuring comfort for patients. 

• Suominen Corporation

Suominen Corporation manufactures nonwoven fabrics that are used in a variety of medical and hygiene applications. Their biomedical non-woven products are widely used in surgical drapes, gowns, and wound care products. Suominen’s commitment to sustainability is evident in their development of biodegradable non-woven fabrics that reduce environmental impact without compromising on performance. The company’s non-woven textiles are well-regarded for their reliability and safety, making them a popular choice in healthcare facilities worldwide. 

Biomedical Non-Woven Textiles Market Share by Manufacturers 

The market share of the key players in the Biomedical Non-Woven Textiles Market is highly competitive, with top manufacturers holding significant portions of the global market. Johnson & Johnson, B. Braun Melsungen AG, and Medline Industries account for a large share of the market, driven by their comprehensive product offerings and strong presence across multiple regions. These companies continue to dominate the market through innovation, strategic partnerships, and an unwavering commitment to product quality. 

The share of the market is further divided based on product lines and geographic presence. North America and Europe account for a significant portion of the market, with companies like Johnson & Johnson and Cardinal Health leading the way. However, the Asia-Pacific region is quickly becoming a key growth area due to its expanding healthcare infrastructure and rising demand for biomedical non-woven textiles. 

Recent News and Industry Developments 

The Biomedical Non-Woven Textiles Market continues to evolve with ongoing technological innovations and shifts in healthcare needs. Key industry players are responding to these trends with product innovations, expansions, and acquisitions: 

• In 2023, Medline Industries expanded its manufacturing capacity for non-woven surgical gowns and drapes to meet the surging demand in both established and emerging markets. 

• Freudenberg Group recently launched a new line of antimicrobial non-woven fabrics for use in wound care and surgical applications. This innovation was aimed at improving patient safety and reducing the risk of infections in medical settings. 

• Kimberly-Clark Professional introduced a new line of eco-friendly, biodegradable non-woven face masks, catering to the growing demand for sustainable medical products. 

• In 2024, DuPont announced a major investment in expanding its Tyvek® production facilities to cater to the increasing demand for high-performance protective apparel in healthcare and other industries. 

These developments reflect the continuous innovation and strategic initiatives undertaken by key players in the Biomedical Non-Woven Textiles Market, as they adapt to the evolving needs of the healthcare sector. 

 

“Biomedical non-woven textiles Production Data and Biomedical non-woven textiles Production Trend”

• • • Biomedical non-woven textiles sales database for historical years, 10 years historical data
    • Biomedical non-woven textiles sales data and forecast for next 7 years